who should get abiraterone in non-metastatic prostate cancer?
Published 8 months ago • 466 plays • Length 0:46Download video MP4
Download video MP3
Similar videos
-
1:00
single agent vs combination in brca positive prostate cancer. #oncology
-
23:11
how to treat prostate cancer in 2024 with dr. rana mckay
-
4:18
abiraterone with or without enzalutamide plus adt for non-metastatic prostate cancer
-
8:56
abiraterone in metastatic prostate cancer
-
1:53
abiraterone vs docetaxel for metastatic castrate resistant prostate cancer
-
4:10
abiraterone in high and low risk, hormone sensitive metastatic prostate cancer
-
1:26
dr. oh discusses choosing abiraterone in prostate cancer
-
1:11
dr. burgess on the synergy between abiraterone and adt in prostate cancer
-
4:14
#prostatecancer doctors: how to choose the right one for you | joel nowak, ceo of cancer abcs | pcri
-
1:08
dr. graff on the use of abiraterone in metastatic prostate cancer
-
2:12
abiraterone for metastatic, hormone sensitive, prostate cancer
-
4:34
card: cabazitaxel vs abiraterone or enzalutamide in metastatic castration-resistant prostate cancer
-
0:45
dr. hahn on patients with prostate cancer whom neither docetaxel or abiraterone is an option
-
7:58
abiraterone and chemotherapy in crpc
-
6:48
adding abiraterone acetate plus prednisolone to standard therapy lengthens survival in non-metas...
-
1:07
unanswered questions and unmet needs in prostate cancer
-
1:37
dr. oh discusses the use of abiraterone and docetaxel in prostate cancer
-
1:54
dr. hahn on patient selection for abiraterone versus docetaxel in mhspc
-
0:31
unmet needs in the use of circulating tumor cells for prostate cancer